Relatively uncommon in the United States before 2000, carbapenem-resistant Enterobacteriaceae (CRE) continue a dramatic increase in health care settings, moving across the health care continuum and causing infections that are difficult to treat and have high mortality, the Centers for…
Patients who tested positive for carbapenem-resistant Enterobacteriaceae (CRE) took an average of 387 days following hospital discharge clear of the organism, according to a new study published in the current issue of the American Journal of Infection Control, the official publication of…
Patient-to-patient transmission of the so-called New Delhi strain of carabapenem-resistant Enterobacteriaceae (CRE) in a Rhode Island hospital was recently reported by the Centers for Disease Control and Prevention. “Clinicians caring for patients infected with such organisms have few, if any,…